I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
[A real-world study focused on the effectiveness and safety..:
Navas-López, Víctor Manuel
;
Pujol Muncunill, Gemma
;
Llerena, Enrique
...
http://hdl.handle.net/10668/11128. , 2017
Link:
http://hdl.handle.net/10668/11128
RT Journal T1
[A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for pediatric Crohn's disease]. ; Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn
UL https://suche.suub.uni-bremen.de/peid=base-ftsspa:oai:www.repositoriosalud.es:10668_11128&Exemplar=1&LAN=DE A1 Navas-López, Víctor Manuel A1 Pujol Muncunill, Gemma A1 Llerena, Enrique A1 Navalón Rubio, María A1 Gil-Ortega, David A1 Varea-Calderón, Vicente A1 Sierra Salinas, Carlos A1 Martin-de-Carpi, Javier YR 2017 K1 Adalimumab K1 Anti-TNF naïve K1 Biologics K1 Biológicos K1 Children K1 Crohn's disease K1 Enfermedad de Crohn K1 Infliximab K1 Naive a anti-TNF K1 Niños K1 Paediatric K1 Pediátrico K1 Adolescent K1 Anti-Inflammatory Agents K1 Child K1 Crohn Disease K1 Female K1 Humans K1 Male K1 Remission Induction K1 Retrospective Studies K1 Treatment Outcome K1 Tumor Necrosis Factor-alpha JF http://hdl.handle.net/10668/11128 LK http://hdl.handle.net/10668/11128 DO http://hdl.handle.net/10668/11128 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)